Myocardial infarction associated with the use of dextrofenfluramine Drs P EVRARD, A F ALLAZ (Clinique Medicale Therapeutique, University Hospital, 1211 Geneva), and P URBAN (Centre de Cardiologie, University Hospital, 1211 Geneva) write: Dextrofenfluramine, an anorexigenic drug, is the dextroisomer form of fenfluramine.' Adverse effects of fenfluramine include fixed or reversible pulmonary hypertension.24 We describe a non-Q wave myocardial infarction that occurred in a woman taking dextrofenfluramine. A 31 year old white woman was admitted with a two hour history of chest pain at rest that was relieved by intravenous nitroglycerin within 45 minutes. The patient was in excellent health with no family history of cardiovascular disease. She did not smoke or drink alcohol and had never used illicit drugs. She had been taking an oral contraceptive pill for the past three years (levonorgestrel 50-75-125 [tg, ethinyloestradiol 30-40-30 [tg). Eight days before admission she had started taking dextrofenfluramine 15 mg three times daily and had lost 6 kg in a week.
Drug Points
Hepatitis B vaccine associated with erythema nodosum and polyarthritis Drs [tg) . Eight days before admission she had started taking dextrofenfluramine 15 mg three times daily and had lost 6 kg in a week.
Physical examination was normal. She was 1 m 65 cm tall and weighed 54 kg. Electrocardiography showed ST elevation of 3 mm in leads V2 and V3, and cardiac enzymes were raised (creatine kinase 457 IU/l (normal range 0-27 IU/l), MB fraction 55 IU/l with a peak of 823 IU/I after five hours). Cardiac catheterisation showed moderate anterior hypokinesia, and findings on technetium-99 m scanning were also consistent with a non-Q wave myocardial infarction. Coronary angiography performed 15 hours after admission showed no abnormality, and the results of viral serology and blood coagulation tests were normal.
Acute and chronic cardiomyopathy as well as myocardial infarction have been described in association with amphetamine administration but not with oral administration of either fenfluramine or dextrofenfluramine.57 Although we cannot exclude the contribution of the oral contraceptive pill in this patient,89 the occurrence of a myocardial infarction a few days after the start of a course of dextrofenfluramine suggests that the drug may have helped to induce the event, possibly by inducing coronary spasm. Our patient took 45 mg a day instead of the recommended dose of 30 mg. Attention should be paid to the possible cardiovascular side effects of dextrofenfluramine, especially in higher dosages.
